Biodexa pharmaceuticals plc to present at the emerging growth conference on february 19, 2025

February 13, 2025 biodexa pharmaceuticals plc to present at the emerging growth conference on february 19, 2025 biodexa pharmaceuticals plc invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the emerging growth conference biodexa pharmaceuticals plc (“biodexa” or “the company”), (nasdaq: bdrx), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs is pleased to announce that it has been invited to present on the emerging growth conference on february 19, 2025. the live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the company's ceo / cfo, stephen stamp in real time.
BDRX Ratings Summary
BDRX Quant Ranking